Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats

Endocrinology

Volumn 137, Issue 5, 1996, Pages 1523-1529

  Arima, Hiroshi ^a   Murase, Takashi ^a   Kondo, Kunikazu ^a   Iwasaki, Yasumasa ^a   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; MACROGOL; NALOXONE; NEUROPEPTIDE FF; OPIATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN STEM; CISTERNA MAGNA; CONTROLLED STUDY; DOSE RESPONSE; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HORMONE RELEASE; HYPEROSMOLALITY; HYPOTHALAMUS; HYPOVOLEMIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OSMOREGULATION; PRIORITY JOURNAL; RAT; SODIUM BLOOD LEVEL; SOLITARY TRACT NUCLEUS;

EID: 0029913729     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.5.8612481     Document Type: Article

References (37)

1. Price DA, Greenberg MJ 1977 Structure of a molluscan cardioexcitatory neuropeptide. Science 197:670-671
2. Yang H-YT, Fratta W, Majane EA, Costa E 1985 Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 82:7757-7761
3. Kavaliers M 1990 Inhibitory influences of mammalian FMRF amide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice. Neurosci Lett 115:307-312
4. 2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides 11:277-280
5. 2-related peptides augments morphine- and stress-induced analgesia in mice. Peptides 10:741-745
6. Lake JR, Hammond MV, Shaddox RC, Hunsicker LM, Yang H-YT, Malin DH 1991 IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci Lett 132:29-32
7. Raffa RB, Kim A, Rice KC, De Costa BR, Codd EE, Rothman RB 1994 Low affinity of FMRF amide and four FaRPs (FMRF amide-related peptides), including the mammalian-derived FaRPs F-8-F amide (NPFF) and A-18-F amide, for opioid μ, δ, κ1, κ2a, or κ2b receptors. Peptides 15:401-404
8. Allard M, Zajac J-M, Simonnet G 1992 Autoradiographic distribution of receptors to FLFQPQRF amide, a morphine-modulating peptide, in rat central nervous system. Neuroscience 49:101-116
9. Kivipelto L, Majane EA, Yang H-YT, Panula P 1989 Immunohistochemical distribution and partial characterization of FLFQPQRF amidelike peptides in the central nervous system of rats. J Comp Neurol 286:269-287
10. Boersma CJC, Sonnemans MAF, Van Leeuwen FW 1993 Immunocytochemical localization of neuropeptide FF (FMRF amide-like peptide) in the hypothalamo-neurohypophyseal system of Wistar and Brattleboro rats by light and electron microscopy. J Comp Neurol 336:555-570
11. 2). Endocrinology 133:1578-1584
12. 2-like peptide in rat pituitary: decrease by osmotic stimulus. Peptides 12:1303-1308
13. Watson SJ, Akil H, Fischli W, Goldstein A, Zimmerman E, Nilaver G, van Wimersma Greidanus TB 1982 Dynorphin and vasopressin: common localization in magnocellular neurons. Science 216:85-87
14. ten Haaf JA, Maigret C, Andringa-Bakker EAD, van Wimersma Greidanus TB 1987 Dynorphin-(1-13) is a potent in vivo suppressor of vasopressin levels in the rat. Acta Endocrinol (Copenh) 114:96-101
15. Robertson GL 1977 The regulation of vasopressin function in health and disease. Recent Prog Horm Res 33:333-385
16. Bisset GW, Chowdrey HS 1988 Control of release of vasopressin by neuroendocrine reflexes. Q J Exp Physiol 73:811-872
17. Share L 1988 Role of vasopressin in cardiovascular regulation. Physiol Rev 68:1248-1284
18. Kalia M, Sullivan JM 1982 Brainstem projections of sensory and motor components of the vagus nerve in the rat. J Comp Neurol 211:248-264
19. Khachaturian H, Lewis ME, Schäfer MK-H, Watson SJ 1985 Anatomy of the CNS opioid systems. Trends Neurosci 8:111-119
20. Ishikawa S, Shrier RW 1982 Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat. J Clin Invest 69:666-672
21. Oiso Y, Iwasaki Y, Kondo K, Takatsuki K, Tomita A 1988 Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Neuroendocrinology 48:658-662
22. Iwasaki Y, Gaskill MB, Boss CA, Robertson GL 1994 The effect of the nonselective opioid antagonist diprenorphine on vasopressin secretion in the rat. Endocrinology 134:48-54
23. Iwasaki Y, Gaskill MB, Robertson GL 1994 The effect of selective opioid antagonists on vasopressin secretion in the rat. Endocrinology 134:55-62
24. Iwasaki Y, Gaskill MB, Fu R, Saper CB, Robertson GL 1993 Opioid antagonist diprenorphine microinjected into parabrachial nucleus selectively inhibits vasopressin response to hypovolemic stimuli in the rat. J Clin Invest 92:2230-2239
25. Malin DH, Lake JR, Leyva JE, Hammond MV, Rogillio RB, Arcangeli KR, Ludgate K, Moore GM, Payza K 1991 Analog of neuropeptide FF attenuates morphine abstinence syndrome. Peptides 12:1011-1014
26. Otake K, Kondo K, Oiso Y 1991 Possible involvement of endogenous opioid peptides in the inhibition of arginine vasopressin release by γ-aminobutyric acid in conscious rats. Neuroendocrinology 54:170-174
27. Kondo K, Murase T, Otake K, Ito M, Oiso Y 1991 Centrally administered galanin inhibits osmotically stimulated arginine vasopressin release in conscious rats. Neurosci Lett 128:245-248
28. Dunn FL, Brennan TJ, Nelson AE, Robertson GL 1973 The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest 52:3212-3219
29. Stricker EM, Verbalis JG 1986 Interaction of osmotic and volume stimuli in regulation of neurohypophyseal secretion in rats. Am J Physiol 250:R267-R275
30. 2-like peptide is deficient in the pituitary gland of the Brattleboro rat. Peptides 11:345-349
31. ten Haaf JA, van Wimersma Greidanus TB, Maigret C, De Wied D 1986 Effect of the opioid peptide beta-endorphin on the in vivo release of vasopressin in rats under various conditions. Neuroendocrinology 44:102-107
32. Bisset GW, Chowdrey HS 1984 A cholinergic link in the reflex release of vasopressin by hypotension in the rat. J Physiol 354:523-545
33. Feldberg W 1976 The ventral surface of the brain stem: a scarcely explored region of pharmacological sensitivity. Neuroscience 1:427-441
34. Paterson SJ, Robson LE, Kosterlitz HW 1983 Classification of opioid receptors. Br Med Bull 39:31-36
35. Clark JA, Liu L, Price M, Hersh B, Edelson M, Pasternak GW 1989 K opiate receptor multiplicity: evidence for two U-50,488-sensitive κ1 subtypes and a novel κ3 subtype. J Pharmacol Exp Ther 251:461-468
36. Berkowitz BA, Ngai SH, Hempstead J, Spector S 1975 Disposition of naloxone: use of a new radioimmunoassay. J Pharmacol Exp Ther 195:499-504
37. 2), inhibit colonic bead expulsion time in mice. Peptides 10:873-875